Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Feb. 01, 2025	Feb. 03, 2024	Jan. 28, 2023
Operating Activities
Net earnings	$ 106,097	$ 171,832	$ 179,695
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation	40,245	36,172	32,449
Amortization of capitalized software	5,147	5,026	4,451
Amortization of intangible assets	11,036	12,082	12,111
Amortization of debt issuance costs and debt discount	407	407	407
Share-based compensation expense	15,145	14,804	17,311
Loss on disposal of property and equipment	421	1,353	1,369
Impairment charges for property, equipment, and lease right-of-use assets	1,864	749	1,803
Adjustment to expected credit losses	(815)	1,018	(262)
Deferred income taxes	19,811	(11,866)	4,270
Changes in operating assets and liabilities:
Receivables	(15,614)	(8,494)	(10,302)
Inventories	(23,289)	39,495	16,242
Prepaid expenses and other current and noncurrent assets	(6,744)	(15,285)	(1,971)
Trade accounts payable	(14,356)	22,038	(101,450)
Accrued expenses and other liabilities	(28,889)	(70,974)	(34,590)
Income taxes, net	(4,250)	1,562	5,896
Other, net	(1,654)	232	(1,550)
Net cash provided by operating activities	104,562	200,151	125,879
Investing Activities
Purchases of property and equipment	(49,147)	(44,584)	(55,913)
Capitalized software	(2,539)	(5,034)	(8,124)
Net cash used for investing activities	(51,686)	(49,618)	(64,037)
Financing Activities
Borrowings under revolving credit agreement	639,868	532,500	859,500
Repayments under revolving credit agreement	(602,368)	(658,000)	(842,000)
Dividends paid	(9,694)	(9,954)	(10,184)
Acquisition of treasury stock	(65,039)	(17,445)	(63,225)
Issuance of common stock under share-based plans, net	(9,276)	(11,094)	(5,387)
Contributions by noncontrolling interests	2,000	1,000	3,142
Net cash used for financing activities	(44,509)	(162,993)	(58,154)
Effect of exchange rate changes on cash and cash equivalents	(89)	118	(103)
Increase (decrease) in cash and cash equivalents	8,278	(12,342)	3,585
Cash and cash equivalents at beginning of period	21,358	33,700	30,115
Cash and cash equivalents at end of period	$ 29,636	$ 21,358	$ 33,700